{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:48:02Z","timestamp":1792496882066,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["HepEDiaSeq.01EK2106A\/B"],"award-info":[{"award-number":["HepEDiaSeq.01EK2106A\/B"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2024_EKEA.09"],"award-info":[{"award-number":["2024_EKEA.09"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["522354957"],"award-info":[{"award-number":["522354957"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["KI 2621\/2"],"award-info":[{"award-number":["KI 2621\/2"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["499292334"],"award-info":[{"award-number":["499292334"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["518559083"],"award-info":[{"award-number":["518559083"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019559","name":"Carl von Ossietzky Universit\u00e4t Oldenburg","doi-asserted-by":"publisher","award":["2021-062"],"award-info":[{"award-number":["2021-062"]}],"id":[{"id":"10.13039\/100019559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tim.2025.03.015","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:15:41Z","timestamp":1745428541000},"page":"866-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["How hepatitis E virus invades hepatocytes: the mystery of viral entry"],"prefix":"10.1016","volume":"33","author":[{"given":"Yannick","family":"Br\u00fcggemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Frericks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emely","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Kinast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2025.03.015_bb0005","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.tim.2025.03.015_bb0010","unstructured":"World Health Organization. Hepatitis E: Fact Sheet, WHO. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e (accessed on 11 March 2025)."},{"key":"10.1016\/j.tim.2025.03.015_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2002324118","article-title":"Ranking the risk of animal-to-human spillover for newly discovered viruses","volume":"118","author":"Grange","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0020","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"Dalton","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tim.2025.03.015_bb0025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","article-title":"Pathogenesis and treatment of hepatitis e virus infection","volume":"142","author":"Wedemeyer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tim.2025.03.015_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/v11060485","article-title":"Hepatitis E virus drug development","volume":"11","author":"Kinast","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2025.03.015_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tim.2025.03.015_bb0040","article-title":"Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment","volume":"6","author":"G\u00f6mer","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.tim.2025.03.015_bb0045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/HEP.0000000000000514","article-title":"Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients","volume":"78","author":"G\u00f6mer","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.tim.2025.03.015_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/v8100283","article-title":"Mutagenic effects of ribavirin on hepatitis E virus \u2013 viral extinction versus selection of fitness-enhancing mutations","volume":"8","author":"Todt","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2025.03.015_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"Nimgaonkar","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tim.2025.03.015_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007471","article-title":"Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion","volume":"14","author":"Gouttenoire","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2025.03.015_bb0065","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","article-title":"Virus\u2013receptor interactions: the key to cellular invasion","volume":"430","author":"Maginnis","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tim.2025.03.015_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro817","article-title":"Virus entry: molecular mechanisms and biomedical applications","volume":"2","author":"Dimitrov","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2025.03.015_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2019.01.007","article-title":"Cell culture systems for the study of hepatitis E virus","volume":"163","author":"Meister","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0080","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0085","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.1912307117","article-title":"Robust hepatitis E virus infection and transcriptional response in human hepatocytes","volume":"117","author":"Todt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0090","article-title":"Modeling extrahepatic hepatitis E virus infection in induced human primary neurons","volume":"121","author":"Jagst","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep4.1138","article-title":"Hepatitis E virus replication and interferon responses in human placental cells","volume":"2","author":"Knegendorf","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tim.2025.03.015_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/v8100267","article-title":"Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line","volume":"8","author":"Schemmerer","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2025.03.015_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199427","article-title":"Colon-derived Caco-2 cells support replication of hepatitis E virus genotype 1 strain Sar55 generated by reverse genetics","volume":"347","author":"Falkenhagen","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0110","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1097\/HEP.0000000000000308","article-title":"EGF receptor modulates HEV entry in human hepatocytes","volume":"77","author":"Schrader","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.tim.2025.03.015_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000553","article-title":"The tyrosine kinase Yes1 is a druggable host factor of HEV","volume":"8","author":"Haase","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tim.2025.03.015_bb0120","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/HEP.0000000000000912","article-title":"Targeting cellular cathepsins inhibits hepatitis E virus entry","volume":"80","author":"Kl\u00f6hn","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.tim.2025.03.015_bb0125","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1073\/pnas.1614955114","article-title":"Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles","volume":"114","author":"Ding","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0130","article-title":"A high-content RNA-based imaging assay reveals integrin beta 1 as a cofactor for cell entry of non-enveloped hepatitis E virus","author":"Fu","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.tim.2025.03.015_bb0135","article-title":"Monitoring of hepatitis E virus infection and replication by functional tagging of the ORF2 protein","volume":"7","author":"Ankavay","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.tim.2025.03.015_bb0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/v15040869","article-title":"Expanding the hepatitis E virus toolbox: selectable replicons and recombinant reporter genomes","volume":"15","author":"Oechslin","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2025.03.015_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01906-21","article-title":"Development of recombinant infectious hepatitis E virus harboring the nanoKAZ Gene and its application in drug screening","volume":"96","author":"Primadharsini","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416255121","article-title":"Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans","volume":"121","author":"Guo","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0155","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1073\/pnas.0904848106","article-title":"Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding","volume":"106","author":"Guu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1099\/vir.0.83308-0","article-title":"Putative receptor-binding sites of hepatitis E virus","volume":"89","author":"He","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0165","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1073\/pnas.0903699106","article-title":"Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure","volume":"106","author":"Yamashita","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41579-023-00889-z","article-title":"Cell entry and release of quasi-enveloped human hepatitis viruses","volume":"9","author":"Das","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2025.03.015_bb0180","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.02804-15","article-title":"Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses","volume":"90","author":"Yin","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0185","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jhep.2022.01.006","article-title":"Hepatitis E virus is highly resistant to alcohol-based disinfectants","volume":"76","author":"Behrendt","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tim.2025.03.015_bb0190","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/jmv.24570","article-title":"Asialoglycoprotein receptor facilitates infection of PLC\/PRF\/5 cells by HEV through interaction with ORF2","volume":"88","author":"Zhang","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0195","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.00717-09","article-title":"Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection","volume":"83","author":"Kalia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2019.07.025","article-title":"Integrin \u03b13 is involved in non-enveloped hepatitis E virus infection","volume":"536","author":"Shiota","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.tim.2025.03.015_bb0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tim.2025.03.015_bb0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00018-023-04977-4","article-title":"The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus","volume":"80","author":"Corneillie","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tim.2025.03.015_bb0215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2893.2011.01559.x","article-title":"Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis","volume":"19","author":"Kapur","year":"2012","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.tim.2025.03.015_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/tra.12260","article-title":"Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway","volume":"16","author":"Holla","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.tim.2025.03.015_bb0225","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1128\/JVI.00750-12","article-title":"Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry","volume":"86","author":"Diao","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0230","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0235","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/pathogens13121130","article-title":"Role of Rab13, protein kinase A, and zonula occludens-1 in hepatitis E virus entry and cell-to-cell spread: comparative analysis of quasi-enveloped and non-enveloped forms","volume":"13","author":"Nagashima","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.tim.2025.03.015_bb0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/v11100883","article-title":"Hepatitis E virus entry","volume":"11","author":"Yin","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2025.03.015_bb0245","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1099\/vir.0.019323-0","article-title":"Role of heat-shock protein 90 in hepatitis E virus capsid trafficking","volume":"91","author":"Zheng","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307423120","article-title":"A genome-wide CRISPR\/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication","volume":"120","author":"Oechslin","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0255","first-page":"839","article-title":"Integrin traffic \u2013 the update","volume":"128","author":"Franceschi","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tim.2025.03.015_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41556-018-0223-z","article-title":"Integrin trafficking in cells and tissues","volume":"21","author":"Moreno-Layseca","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tim.2025.03.015_bb0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43983","article-title":"Cellular entry and uncoating of naked and quasi-enveloped human hepatoviruses","volume":"8","author":"Rivera-Serrano","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.tim.2025.03.015_bb0270","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1128\/JVI.00403-08","article-title":"The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response","volume":"82","author":"Chandra","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0275","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1128\/JVI.01994-09","article-title":"The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex","volume":"84","author":"Chandra","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0280","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.3390\/ijms23169089","article-title":"The key role of lysosomal protease cathepsins in viral infections","volume":"23","author":"Scarcella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tim.2025.03.015_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01504-18","article-title":"Lysosomal proteases are a determinant of coronavirus tropism","volume":"92","author":"Zheng","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.aan6298","article-title":"Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes","volume":"358","author":"Abu-Remaileh","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tim.2025.03.015_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104997","article-title":"Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90","volume":"185","author":"Nimgaonkar","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-024-00634-1","article-title":"The chemokine receptor CCR5: multi-faceted hook for HIV-1","volume":"21","author":"Faivre","year":"2024","journal-title":"Retrovirology"},{"key":"10.1016\/j.tim.2025.03.015_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106062","article-title":"Host-targeting antivirals for chronic viral infections of the liver","volume":"234","author":"Frericks","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0310","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-025-57182-1","article-title":"Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice","volume":"16","author":"Ssebyatika","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2025.03.015_bb0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2213429","article-title":"A phase 3, randomized trial of bulevirtide in chronic hepatitis D","volume":"389","author":"Wedemeyer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2025.03.015_bb0320","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2025.03.015_bb0325","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41575-024-00950-z","article-title":"Hepatitis E virus: from innate sensing to adaptive immune responses","volume":"21","author":"Br\u00fcggemann","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tim.2025.03.015_bb0330","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00705-015-2579-8","article-title":"Beyond RGD: virus interactions with integrins","volume":"160","author":"Hussein","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.tim.2025.03.015_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183296","article-title":"Hepatitis C virus infection and tight junction proteins: The ties that bind","volume":"1862","author":"Mailly","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.tim.2025.03.015_bb0340","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virusres.2010.12.011","article-title":"Intergenotypic chimeric hepatitis E viruses (HEVs) with the genotype 4 human HEV capsid gene in the backbone of genotype 3 swine HEV are infectious in pigs","volume":"156","author":"Feagins","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0345","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gene.2018.06.108","article-title":"Conservation and variation of the hepatitis E virus ORF2 capsid protein","volume":"675","author":"Zhang","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.tim.2025.03.015_bb0350","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","article-title":"Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Huang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2025.03.015_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1011662","article-title":"Hepatitis E genotype 3 genome: a comprehensive analysis of entropy, motif conservation, relevant mutations, and clade-associated polymorphisms","volume":"13","author":"Mu\u00f1oz-Chimeno","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tim.2025.03.015_bb0360","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202653119","article-title":"A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function","volume":"119","author":"Meister","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2025.03.015_bb0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2013.05.013","article-title":"Rabbit and human hepatitis E virus strains belong to a single serotype","volume":"176","author":"Wang","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.tim.2025.03.015_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000537","article-title":"Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus\u2013host interaction","volume":"5","author":"Li","year":"2009","journal-title":"PLoS Pathog."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X25001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X25001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:12:30Z","timestamp":1768601550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X25001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0966842X25001118"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2025.03.015","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How hepatitis E virus invades hepatocytes: the mystery of viral entry","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2025.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}